Sound View Wealth Advisors Group, LLC Gilead Sciences, Inc. Transaction History
Sound View Wealth Advisors Group, LLC
- $1.34 Billion
- Q2 2025
A detailed history of Sound View Wealth Advisors Group, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Sound View Wealth Advisors Group, LLC holds 27,134 shares of GILD stock, worth $2.99 Million. This represents 0.23% of its overall portfolio holdings.
Number of Shares
27,134
Previous 10,127
167.94%
Holding current value
$2.99 Million
Previous $1.13 Million
165.26%
% of portfolio
0.23%
Previous 0.09%
Shares
21 transactions
Others Institutions Holding GILD
# of Institutions
2,295Shares Held
1BCall Options Held
9.59MPut Options Held
10M-
Black Rock Inc. New York, NY121MShares$13.3 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA117MShares$13 Billion0.25% of portfolio
-
State Street Corp Boston, MA59.5MShares$6.56 Billion0.28% of portfolio
-
Capital Research Global Investors Los Angeles, CA54.6MShares$6.02 Billion1.39% of portfolio
-
Capital World Investors Los Angeles, CA53.5MShares$5.91 Billion1.01% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $138B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...